JPMorgan Chase & Co’s Abeona Therapeutics ABEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.72M Buy
831,132
+597,373
+256% +$3.39M ﹤0.01% 2759
2025
Q1
$1.11M Buy
233,759
+233,745
+1,669,607% +$1.11M ﹤0.01% 3590
2024
Q4
$78 Sell
14
-67,124
-100% -$374K ﹤0.01% 5995
2024
Q3
$424K Buy
67,138
+28,606
+74% +$181K ﹤0.01% 4114
2024
Q2
$163K Buy
38,532
+16,868
+78% +$71.5K ﹤0.01% 4367
2024
Q1
$157K Buy
21,664
+21,650
+154,643% +$157K ﹤0.01% 4549
2023
Q4
$70 Hold
14
﹤0.01% 6120
2023
Q3
$59 Hold
14
﹤0.01% 6011
2023
Q2
$56 Sell
14
-704
-98% -$2.82K ﹤0.01% 5828
2023
Q1
$2K Buy
718
+704
+5,029% +$1.96K ﹤0.01% 5529
2022
Q4
$0 Sell
14
-1
-7% ﹤0.01% 5534
2022
Q3
$0 Hold
15
﹤0.01% 5493
2022
Q2
$0 Sell
15
-268
-95% ﹤0.01% 5550
2022
Q1
$2K Sell
283
-49,572
-99% -$350K ﹤0.01% 5577
2021
Q4
$420K Sell
49,855
-21,758
-30% -$183K ﹤0.01% 4167
2021
Q3
$2.01M Sell
71,613
-9,267
-11% -$259K ﹤0.01% 3182
2021
Q2
$3.15M Buy
80,880
+4,338
+6% +$169K ﹤0.01% 2937
2021
Q1
$3.6M Buy
76,542
+50,428
+193% +$2.37M ﹤0.01% 2868
2020
Q4
$1.03M Buy
26,114
+8,696
+50% +$341K ﹤0.01% 3362
2020
Q3
$483K Buy
17,418
+3,537
+25% +$98.1K ﹤0.01% 3400
2020
Q2
$1.01M Buy
13,881
+3,638
+36% +$265K ﹤0.01% 3004
2020
Q1
$538K Buy
10,243
+9,821
+2,327% +$516K ﹤0.01% 3260
2019
Q4
$35K Hold
422
﹤0.01% 4330
2019
Q3
$24K Buy
422
+68
+19% +$3.87K ﹤0.01% 4435
2019
Q2
$42K Buy
354
+49
+16% +$5.81K ﹤0.01% 4321
2019
Q1
$56K Sell
305
-3,754
-92% -$689K ﹤0.01% 4188
2018
Q4
$725K Sell
4,059
-163
-4% -$29.1K ﹤0.01% 3201
2018
Q3
$1.35M Sell
4,222
-2,898
-41% -$927K ﹤0.01% 2995
2018
Q2
$2.85M Sell
7,120
-1,487
-17% -$595K ﹤0.01% 2599
2018
Q1
$3.09M Sell
8,607
-784
-8% -$281K ﹤0.01% 2507
2017
Q4
$3.72M Buy
+9,391
New +$3.72M ﹤0.01% 2426
2016
Q3
Sell
-19
Closed -$1K 4056
2016
Q2
$1K Buy
+19
New +$1K ﹤0.01% 4136